Mayo Clinic: Obese Patients With HER2-Positive Breast Cancer May Have Worse Outcomes

[News]

Obese patients with early-stage HER2-positive breast cancer may have worse outcomes than patients who are normal weight or overweight, Mayo Clinic researchers found in a study presented today at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. HER2-positive breast cancer gets its name from a protein called human epidermal growth factor receptor 2 that promotes cancer cell growth...

More... (http://www.medicalnewstoday.com/releases/238933.php)